Vantictumab: Interim Ph Ib data

Interim data from 21 evaluable patients in an open-label, dose-escalation, U.S. Phase Ib trial showed that IV vantictumab on days

Read the full 202 word article

How to gain access

Continue reading with a
two-week free trial.